Malgorzata Nowakowska
About Malgorzata Nowakowska
Malgorzata Nowakowska is the Associate Director of Clinical Operation for Central Eastern Europe and Turkey at Bristol Myers Squibb, with over 25 years of experience in clinical operations and management within the pharmaceutical industry.
Company
Malgorzata Nowakowska is currently employed at Bristol Myers Squibb, a global biopharmaceutical company. She holds a significant role within the company, focusing on clinical operations for Central Eastern Europe and Turkey. Bristol Myers Squibb is known for its dedication to innovative research and development in the pharmaceutical industry.
Title
Malgorzata Nowakowska serves as the Associate Director of Clinical Operations for Central Eastern Europe and Turkey at Bristol Myers Squibb. In this capacity, she oversees clinical trial management and operations across several countries in these regions.
Education and Expertise
Malgorzata Nowakowska studied at the University of Warsaw from 1985 to 1991. She has accumulated over 25 years of experience in clinical operations and management within the pharmaceutical industry. Her expertise lies in managing clinical trials and cross-functional teams across multiple countries, including Poland, Hungary, the Czech Republic, Slovakia, and the Baltics.
Background
Malgorzata Nowakowska has a diverse background in clinical operations. She started her career at SmithKline Beecham Corporation as a Clinical Trial Manager/Clinical Research Associate, where she worked from 1995 to 2001. She then joined PAREXEL as a Line Manager in Warsaw for a year. She has held various roles at Bristol Myers Squibb, including Head of Site Monitors and Clinical Operations Manager, demonstrating a steady progression in her career.
Achievements
Throughout her career, Malgorzata Nowakowska has played a key role in expanding clinical operations across Central Eastern Europe and Turkey. Her management of clinical trials in multiple countries and her ability to oversee complex clinical trials and cross-functional teams highlight her significant contributions to the pharmaceutical industry.